(MedPage Today) — In a lawsuit, Texas Attorney General Ken Paxton alleged that Eli Lilly bribed healthcare providers to prescribe its most profitable drugs, including the GLP-1 agonist tirzepatide (Mounjaro, Zepbound).
A 52-study meta-analysis…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/116960
Author :
Publish date : 2025-08-12 19:29:00
Copyright for syndicated content belongs to the linked Source.
